15 employees
Bottneuro develops Digital therapies for Alzheimer's Disease using Electrical stimulation of glia cells in the brain.
2021
$4.3M
from 3 investors over 3 rounds
Bottneuro AG raised $4.3M on December 15, 2022
Investors: -, DART Labs I Ventures and HEMEX AG